CSIMarket
 
Maxcyte inc   (MXCT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Maxcyte Inc Growth Comparisons

Select each growth Category to receive further Information



MXCT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 26.09 % -7.19 % - -
Q / Q Revenue Growth (Q4 MRQ) 95.7 % - - -
Y / Y Revenue Growth (for 12 months ending Q4 TTM) -6.72 % - - %
Seq. Revenue Growth (for 12 months ending Q4 TTM) 8.52 % - - 0.28 %
Revenue 5 Year Average Growth - 10.74 % 7.43 % 8.42 %


MXCT's Growth Comparisons in IV. Quarter 2023




Maxcyte Inc showed impressive 26.09% year on year rise in the forth quarter 2023 to 16 millions, despite the -7.19% in the Medical Laboratories industry, Healthcare sector remained unchanged %.

Top-line grew by 95.7% from the third quarter. Average yearly sales growth for Maxcyte Inc is %, while S & P 500's average annual sales increase is 8.42% over the five years, including only Businesses with the forth quarter 2023 Results.


Growth Rates of MXCT's Income in the forth quarter 2023


MXCT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 15.83 % - -
Seq. Operating Income Change (Q4 MRQ) - -56.02 % - -
Y / Y Operating Income Growth (Q4 TTM) - 15.25 % -34.88 % -3.43 %
Seq. Operating Income Growth (Q4 TTM) - 62.84 % -12.68 % -0.66 %
Operating Income 5 Year Avg. Change - 5.7 % -0.84 % 8.47 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - 125.24 % -21.62 % 3.99 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) - -45.94 % 43.45 % -15.03 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - 36.75 % -27.22 % -0.89 %
Seq. Income from Cont. Ops. Change (Q4 TTM) - 187.94 % 12.13 % 1.58 %
Income from Cont. Ops. 5 Year Avg. Change - 4.86 % -5.15 % 7.68 %

MXCT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 126.25 % -21.16 % -0.54 %
Q / Q Net Income Growth (Q4 MRQ) - -45.65 % -49.98 % -22.01 %
Y / Y Net Income Change (Q4 TTM) - 39.84 % -4.03 % 0.38 %
Seq. Net Income Change (Q4 TTM) - 177.05 % 9.02 % 0.51 %
Net Income 5 Year Avg. Growth - 4.84 % 0.09 % 7.9 %

MXCT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 111.17 % -21.62 % 3.99 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - -45.47 % 43.45 % -15.03 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) - 920.92 % - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth - -5.46 % -5.15 % 7.68 %



MXCT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 112.12 % -21.16 % -0.54 %
Q / Q EPS Net Growth (Q4 MRQ) - -45.18 % -49.98 % -22.01 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 40138.2 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) - 1.66 % - 0.03 %
EPS Net 5 Year Avg. Change - 4.84 % 0.09 % 7.9 %



Maxcyte Inc reported bottom-line of $ -0.05 in the forth quarter, compare to $ -0.04 in the same quarter a year ago. Medical Laboratories industry grew by 112.12%, while Healthcare sector decreased by -21.16%, and overall market declined by -0.54%.

The bottom-line grew by 95.7% from the third quarter. Average yearly income per share growth for Maxcyte Inc is %, while S & P 500's average annual income per share increase is 7.9% over the five years, including only Businesses with the forth quarter 2023 earnings reports.

MXCT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 10.85 % -13.75 % -9.09 %
Seq. Free Cash Flow Change (Q4 MRQ) - 1471.34 % -10.35 % -3.86 %
Y / Y Free Cash Flow Change (Q4 TTM) - -2.95 % -10.46 % 0.96 %
Seq. Free Cash Flow Change (Q4 TTM) - 2.84 % -2.29 % 3.16 %
Free Cash Flow 5 Year Avg. Change - 22.69 % 9.42 % 10.08 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - 169.91 % - -
Seq. Net Cash Flow Change (Q4 MRQ) - -65.71 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Seq. Net Cash Flow Change (Q4 TTM) - 24.68 % -44.6 % -
Net Cash Flow 5 Year Avg. Change - 17.37 % 10.62 % -31.51 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -58.32 % -13.79 % -3.95 % -17.21 %
Seq. Capital Expenditures Change (Q4 MRQ) 27.02 % 39.44 % 10.96 % -0.74 %
Y / Y Capital Expenditures Change (Q4 TTM) -79.98 % -9.55 % 7.71 % 18.67 %
Seq. Capital Expenditures Change (Q4 TTM) -25.7 % -6 % 2.63 % 26.43 %
Capital Expenditures 5 Year Avg. Change - 7.03 % 7.99 % 8.09 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com